36.77
+1.02
+(2.85%)
At close: April 15 at 4:00:00 PM EDT
34.20
-2.57
(-6.99%)
Pre-Market: 6:02:33 AM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 9.79M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| SANTOS DA SILVA JORGE Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 27, 2025 |
| BODENSTEDT MATTHIAS Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 27, 2025 |
| REICH KRISTIAN Officer | -- | Direct | -- | Jan 17, 2025 |
| BVF PARTNERS L P Beneficial Owner of more than 10% of a Class of Security | Sale at price 50.00 per share. | Indirect | 100,003,200 | Oct 4, 2024 |
| STURGE SIMON J Director | Sale at price 53.72 per share. | Direct | 9,186,120 | Oct 4, 2024 |
| SANTOS DA SILVA JORGE Chief Executive Officer | Sale at price 55.00 - 55.89 per share. | Direct | 6,803,044 | Feb 29, 2024 |
| REICH KRISTIAN Officer | Sale at price 55.00 per share. | Indirect | 6,540,710 | Feb 28, 2024 |
| SANTOS DA SILVA JORGE Chief Executive Officer | Sale at price 55.27 per share. | Direct | 62,179 | Feb 21, 2024 |
| REICH KRISTIAN Officer | Sale at price 55.30 - 57.45 per share. | Indirect | 1,208,418 | Feb 21, 2024 |
| SANTOS DA SILVA JORGE Chief Executive Officer | Sale at price 57.44 - 60.18 per share. | Direct | 3,555,400 | Feb 20, 2024 |
| REICH KRISTIAN Officer | Sale at price 60.15 - 62.43 per share. | Indirect | 3,654,800 | Feb 16, 2024 |
| BODENSTEDT MATTHIAS Chief Financial Officer | Sale at price 58.34 - 59.22 per share. | Direct | 5,917,368 | Dec 20, 2023 |
| CHEN BIHUA X. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 59.90 per share. | Indirect | 3,524,297 | Oct 5, 2023 |
| CHEN BIHUA X. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 57.25 - 57.37 per share. | Indirect | 16,800,343 | Oct 4, 2023 |
| SANTOS DA SILVA JORGE Chief Executive Officer | -- | Direct | -- | Sep 29, 2023 |
| BODENSTEDT MATTHIAS Chief Financial Officer | -- | Direct | -- | Sep 29, 2023 |
| REICH KRISTIAN Officer | -- | Indirect | -- | Sep 29, 2023 |
| STURGE SIMON J Director | -- | Direct | -- | Sep 29, 2023 |
| CHEN BIHUA X. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 50.00 per share. | Indirect | 40,000,000 | Jun 30, 2023 |
| CHEN BIHUA X. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 36.91 - 54.92 per share. | Indirect | 20,464,191 | Jun 26, 2023 |
| BODENSTEDT MATTHIAS Chief Financial Officer | -- | Direct | -- | Apr 5, 2023 |
| REICH KRISTIAN Officer | -- | Indirect | -- | Apr 5, 2023 |
| CHEN BIHUA X. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 19.36 - 21.70 per share. | Indirect | 16,774,846 | Mar 21, 2023 |
| CHEN BIHUA X. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 13.25 per share. | Indirect | 37,762,500 | Apr 5, 2022 |
| CHEN BIHUA X. Beneficial Owner of more than 10% of a Class of Security | -- | Indirect | -- | Apr 5, 2022 |
| HELIX HOLDINGS L.L.C. Unknown | -- | Indirect | -- | Apr 5, 2022 |
| CHEN BIHUA X. Chief Executive Officer | Purchase at price 10.00 per share. | Indirect | 4,300,000 | Oct 22, 2020 |
| HELIX HOLDINGS L.L.C. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 10.00 per share. | Direct | 4,300,000 | Oct 22, 2020 |
Related Tickers
VRDN Viridian Therapeutics, Inc.
12.80
-3.76%
APGE Apogee Therapeutics, Inc.
32.85
-1.29%
MRUS Merus N.V.
43.22
+1.86%
SYRE Spyre Therapeutics, Inc.
12.71
-2.38%
DNTH Dianthus Therapeutics, Inc.
19.21
+2.67%
BPMC Blueprint Medicines Corporation
81.45
-1.31%
VERA Vera Therapeutics, Inc.
21.59
+0.42%
TRML Tourmaline Bio, Inc.
14.93
+5.96%
IRON Disc Medicine, Inc.
41.31
+2.58%
KYMR Kymera Therapeutics, Inc.
25.46
+0.12%